Trials / Completed
CompletedNCT00140972
A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)
A Multicenter, Randomized, Parallel-group, 4-Week, Double-Blind and Active Comparator-Controlled Study to Assess Efficacy, Safety, and Tolerability of Etoricoxib 60 mg Once Daily Versus Diclofenac Sodium 75 mg Twice Daily in the Treatment of Chinese Patients With Osteoarthritis of the Knee or Hip
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
A Study to Assess Etoricoxib versus Diclofenac in Chinese Patients with Osteoarthritis of the Knee or Hip
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0663; etoricoxib / Duration of Treatment:4 Weeks | |
| DRUG | Comparator: diclofenac sodium tablet 75 mg / Duration of Treatment:4 Weeks |
Timeline
- Start date
- 2004-12-03
- Primary completion
- 2005-06-27
- Completion
- 2005-06-27
- First posted
- 2005-09-01
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00140972. Inclusion in this directory is not an endorsement.